1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow GSK3008348: new trials by email Literature Review of GSK3008348 trials Research Report on GSK3008348
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Single Doses of GSK3008348 in Idiopathic Pulmonary Fibrosis (IPF) Participants Using Positron Emission Tomography (PET) Imaging GSK3008348, Placebo, [18F]-FBA-A20FMDV2 - Idiopathic Pulmonary Fibrosis | Phase 1 | Terminated | GlaxoSmithKline | 8 | 2017-06-13 | 2019-08-12 |
Idiopathic Pulmonary Fibrosis (1)
GlaxoSmithKline (1)
United Kingdom (1)
2016 (1)